To test this, we transfected BC cell lines with CRISPR-dCas9 constructs fused with epigenetic modifiers alongside guides to the promoters of the tumor suppressor p21, the tumor suppressor p53, and the oncogene CCND1. This evidence concerns the gene TP53 and breast cancer.